These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 8514854

  • 1. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 3. Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer.
    El Abdaimi K, Papavasiliou V, Rabbani SA, Rhim JS, Goltzman D, Kremer R.
    Cancer Res; 1999 Jul 15; 59(14):3325-8. PubMed ID: 10416587
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
    Yu J, Papavasiliou V, Rhim J, Goltzman D, Kremer R.
    Anticancer Drugs; 1995 Feb 15; 6(1):101-8. PubMed ID: 7756673
    [Abstract] [Full Text] [Related]

  • 5. 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion.
    Cohen-Solal ME, Bouizar Z, Denne MA, Graulet AM, Gueris J, Bracq S, Jullienne A, de Vernejoul MC.
    Horm Metab Res; 1995 Sep 15; 27(9):403-7. PubMed ID: 8557238
    [Abstract] [Full Text] [Related]

  • 6. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV, Bai W.
    Clin Cancer Res; 2005 Jan 01; 11(1):323-8. PubMed ID: 15671562
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. Effects of 1,25(OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88.
    Kunakornsawat S, Rosol TJ, Capen CC, Middleton RP, Hannah SS, Inpanbutr N.
    Anticancer Res; 2001 Nov 01; 21(5):3355-63. PubMed ID: 11848494
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 11. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY, Mercer E, Brady M, Binderup L, Colston KW.
    Br J Pharmacol; 1998 Nov 01; 125(5):953-62. PubMed ID: 9846632
    [Abstract] [Full Text] [Related]

  • 12. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
    Shukeir N, Arakelian A, Kadhim S, Garde S, Rabbani SA.
    Cancer Res; 2003 May 01; 63(9):2072-8. PubMed ID: 12727822
    [Abstract] [Full Text] [Related]

  • 13. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K, Katsumata K, Hirata M, Masaki T, Kubodera N, Nakamura T, Ikeda K, Ogata E.
    J Bone Miner Res; 2000 Jan 01; 15(1):175-81. PubMed ID: 10646127
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC, Holick MF, Lokeshwar BL, Burnstein KL, Schwartz GG.
    Recent Results Cancer Res; 2003 Jan 01; 164():273-88. PubMed ID: 12899529
    [Abstract] [Full Text] [Related]

  • 15. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, Akatsu T, Nagata N, Kasahara T, Ohkawa H.
    J Bone Miner Res; 1993 Jul 01; 8(7):849-60. PubMed ID: 8352067
    [Abstract] [Full Text] [Related]

  • 16. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.
    Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM.
    J Clin Invest; 1986 Nov 01; 78(5):1296-301. PubMed ID: 3771798
    [Abstract] [Full Text] [Related]

  • 17. Regulation of parathyroid cell gene expression in experimental uremia.
    Shvil Y, Naveh-Many T, Barach P, Silver J.
    J Am Soc Nephrol; 1990 Jul 01; 1(1):99-104. PubMed ID: 2104257
    [Abstract] [Full Text] [Related]

  • 18. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J.
    Endocrinology; 1998 Apr 01; 139(4):2102-10. PubMed ID: 9528999
    [Abstract] [Full Text] [Related]

  • 19. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
    Aklilu F, Park M, Goltzman D, Rabbani SA.
    Cancer Res; 1997 Oct 15; 57(20):4517-22. PubMed ID: 9377563
    [Abstract] [Full Text] [Related]

  • 20. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF.
    J Bone Miner Res; 2005 Oct 15; 20(10):1792-803. PubMed ID: 16160737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.